These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Strategies for the scale-up of antiretroviral therapy in South Africa through health system optimization. Barker PM; McCannon CJ; Mehta N; Green C; Youngleson MS; Yarrow J; Bennett B; Berwick DM J Infect Dis; 2007 Dec; 196 Suppl 3():S457-63. PubMed ID: 18181694 [TBL] [Abstract][Full Text] [Related]
9. Brazil's fight against AIDS and its implications for global health governance. Wogart JP; Calcagnotto G Healthc Q; 2006; 9(1):76-89. PubMed ID: 16548439 [TBL] [Abstract][Full Text] [Related]
10. World Bank meeting concludes drug resistance should not prevent distribution of antiretroviral therapy to poor countries. Kuritzkes D; Lange J; Zewdie D Nat Med; 2003 Nov; 9(11):1343-4. PubMed ID: 14595419 [No Abstract] [Full Text] [Related]
11. Trips and public health: solutions for ensuring global access to essential AIDS medication in the wake of the Paragraph 6 Waiver. Greenbaum JL J Contemp Health Law Policy; 2008; 25(1):142-65. PubMed ID: 19137750 [No Abstract] [Full Text] [Related]
12. Understanding the costs of pharmaceuticals. Valenti WM AIDS Read; 2004 Sep; 14(9):467-8, 471. PubMed ID: 15457597 [No Abstract] [Full Text] [Related]
13. AIDS epidemic can be ended by 2030, report says. Gulland A BMJ; 2014 Nov; 349():g7062. PubMed ID: 25412713 [No Abstract] [Full Text] [Related]
14. HIV/AIDS. The great funding surge. Cohen J Science; 2008 Jul; 321(5888):512-9. PubMed ID: 18653876 [No Abstract] [Full Text] [Related]
15. AIDS drug programs tighten belts even as medications are shown to curb contagion. Trubo R JAMA; 2011 Jul; 306(3):253-5. PubMed ID: 21771980 [No Abstract] [Full Text] [Related]
16. Emerging retroviral regimens for the developing world--"stop AIDS; keep the promise". Joshi SR J Assoc Physicians India; 2006 Dec; 54():911-3. PubMed ID: 17334005 [No Abstract] [Full Text] [Related]
17. WHO insists it can meet its target for antiretrovirals by 2005. Fleck F BMJ; 2004 Jul; 329(7458):129. PubMed ID: 15258053 [No Abstract] [Full Text] [Related]
18. Retroviral rebound syndrome with fatal outcome after discontinuation of antiretroviral therapy. Garlin AB; Sax PE Clin Infect Dis; 2005 Nov; 41(9):e83-5. PubMed ID: 16206091 [TBL] [Abstract][Full Text] [Related]